Drug firms' payments and physicians’ prescribing behavior in Medicare Part D
Year of publication: |
2021
|
---|---|
Authors: | Carey, Colleen ; Lieber, Ethan M. J. ; Miller, Sarah |
Published in: |
Journal of public economics. - Amsterdam [u.a.] : Elsevier, ISSN 0047-2727, ZDB-ID 183995-0. - Vol. 197.2021, p. 1-14
|
Subject: | Marketing | Physician behavior | Prescription drugs | Arzneimittel | Pharmaceuticals | Ärzte | Physicians | Pharmaindustrie | Pharmaceutical industry | Pharmahandel | Pharmaceutical distributors | Leistungsanreiz | Performance incentive | Gesetzliche Krankenversicherung | Public health insurance | Gesundheitskosten | Health care costs |
-
Should we prevent off-label drug prescriptions? : empirical evidence from France
Tunçel, Tuba, (2022)
-
Drug Firms' Payments and Physicians' Prescribing Behavior in Medicare Part D
Carey, Colleen Marie, (2015)
-
Drug Firms' Payments and Physicians' Prescribing Behavior in Medicare Part D
Carey, Colleen M., (2020)
- More ...
-
Drug firms' payments and physicians' prescribing behavior in Medicare Part D
Carey, Colleen, (2020)
-
The Impact of Provider Payments on Health Care Utilization : Evidence from Medicare and Medicaid
Cabral, Marika, (2021)
-
Drug Firms' Payments and Physicians' Prescribing Behavior in Medicare Part D
Carey, Colleen, (2020)
- More ...